Sharechat Logo

Fears new law will kill face to face financial advice marketing

Monday 25th June 2012

Text too small?

Financial advisers fear the Financial Markets Conduct Bill will kill their ability to market directly to prospective customers by banning unsolicited meetings.

The Institute of Finance Advisers has pleaded with the commerce select committee to change clause 71 of the proposed legislation, which prohibits the offer of financial products resulting from an unsought meeting with an adviser.

“Clients do not in general contact an adviser,” the IFA says. “As it’s now proposed, no adviser would be able to approach any prospective client because it will almost certainly result in a sale further down the line”.

That could make it "impossible for an adviser to gain new clients."

IFA chief executive Peter Lee says the association's submission reflects "considerable industry disquiet", especially as financial advisers are already subject to fresh law and regulation under the recently passed Financial Advisers Act.

“As the clause is written, it doesn’t matter how many meetings you have," said Lee. "If the first one was unsolicited then you can’t offer products."

The IFA also queried in its submission why “quoted securities” were exempted. “Why should an adviser offering shares be exempted, when the same adviser offering the same shares via a managed fund would be caught?”

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report